ObjectiveTo compare the clinical outcomes of follicular versus luteal phase ovarian
stimulation in women with poor ovarian response (Bologna criteria)
undergoing IVF.MethodsThis retrospective study investigated 446 patients submitted to 507 cycles in
three groups. First, the two larger cohorts were examined: 154 patients
treated with luteal phase ovarian stimulation (Group Lu); and 231 patients
administered follicular phase ovarian stimulation (Group Fo). Then the
clinical outcomes of 61 patients submitted to double ovarian stimulation
were analyzed. Clinical outcomes included number of retrieved oocytes,
fertilization rate, cleavage rate, top-quality embryo rate, clinical
pregnancy rate (CPR), and live birth rate (LBR).ResultsLonger stimulation, higher dosages of HMG, and higher MII oocyte rates were
achieved in Group Lu (p<0.001). There were no
significant differences in CPR and LBR between the two groups offered
frozen-thawed embryo transfer (28.4% vs. 33.0%, p=0.484;
22.9% vs. 25.5%, p=0.666). In the double ovarian
stimulation group, the number of oocytes retrieved in the luteal phase
stimulation protocol was higher (p=0.035), although luteal
phase stimulation yielded a lower rate of MII oocytes
(p=0.031). CPR and LBR were not statistically different
(13.8% vs. 21.4%, p=0.525; 10.3% vs. 14.3%,
p=0.706).ConclusionLuteal phase ovarian stimulation may be a promising protocol to treat women
with POR, particularly for patients unable to yield enough viable embryos
through follicular phase ovarian stimulation or other protocols.